CRISPR THERAPEUTICS AG |
Market Closed -
Other stock markets
|
Pre-market 08:34:17 am | |||
| 58.26 USD | +1.94% |
|
59.05 | +1.36% |
| May. 23 | CRISPR Therapeutics Names Naimish Patel as Chief Medical Officer; Promotes Julianne Bruno to Chief Operating Officer | MT |
| May. 23 | CRISPR Therapeutics Announces Executive Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRISPR THERAPEUTICS AG | Other Biotechnology & Medical Research | +1.94% | +6.24% | -6.93% | -10.37% | +56.36% | 4.95B |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- CRSP Stock
- Charts CRISPR Therapeutics AG
- Comparison Chart
